OncoCyte Corp (OCX)
2.525
+0.04
(+1.81%)
USD |
NASDAQ |
Apr 29, 16:00
2.51
-0.02
(-0.59%)
After-Hours: 20:00
OncoCyte Price to Book Value: 1.645 for April 29, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 29, 2024 | 1.645 |
| April 26, 2024 | 1.616 |
| April 25, 2024 | 1.59 |
| April 24, 2024 | 1.603 |
| April 23, 2024 | 1.600 |
| April 22, 2024 | 1.636 |
| April 19, 2024 | 1.629 |
| April 18, 2024 | 1.668 |
| April 17, 2024 | 1.688 |
| April 16, 2024 | 1.792 |
| April 15, 2024 | 1.649 |
| April 12, 2024 | 1.095 |
| April 11, 2024 | 1.198 |
| April 10, 2024 | 1.175 |
| April 09, 2024 | 1.176 |
| April 08, 2024 | 1.172 |
| April 05, 2024 | 1.172 |
| April 04, 2024 | 1.188 |
| April 03, 2024 | 1.188 |
| April 02, 2024 | 1.182 |
| April 01, 2024 | 1.203 |
| March 28, 2024 | 1.182 |
| March 27, 2024 | 1.203 |
| March 26, 2024 | 1.21 |
| March 25, 2024 | 1.218 |
| Date | Value |
|---|---|
| March 22, 2024 | 1.235 |
| March 21, 2024 | 1.231 |
| March 20, 2024 | 1.239 |
| March 19, 2024 | 1.211 |
| March 18, 2024 | 1.219 |
| March 15, 2024 | 1.203 |
| March 14, 2024 | 1.191 |
| March 13, 2024 | 1.215 |
| March 12, 2024 | 1.215 |
| March 11, 2024 | 1.195 |
| March 08, 2024 | 1.211 |
| March 07, 2024 | 1.211 |
| March 06, 2024 | 1.215 |
| March 05, 2024 | 1.219 |
| March 04, 2024 | 1.211 |
| March 01, 2024 | 1.211 |
| February 29, 2024 | 1.174 |
| February 28, 2024 | 1.195 |
| February 27, 2024 | 1.195 |
| February 26, 2024 | 1.231 |
| February 23, 2024 | 1.237 |
| February 22, 2024 | 1.230 |
| February 21, 2024 | 1.239 |
| February 20, 2024 | 1.239 |
| February 16, 2024 | 1.211 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3921
Minimum
Dec 20 2022
17.01
Maximum
Feb 16 2021
3.006
Average
2.463
Median
Aug 20 2020
Price to Book Value Benchmarks
| Fonar Corp | 0.6338 |
| XWELL Inc | 0.5663 |
| ProPhase Labs Inc | 1.685 |
| Applied DNA Sciences Inc | 0.785 |
| Veracyte Inc | 1.462 |
Price to Book Value Related Metrics
| PS Ratio | 12.84 |
| Price | 2.525 |
| Earnings Yield | -140.6% |
| Market Cap | 33.68M |